Friday 13th June 2003
|Text too small?|
The "multi-disciplined healthcare and medical services" company's share price has been a flatliner since late in 2000 when chief executive Alan Clarke took over, the board got a shake-up and a major restructuring got under way.
Mr Clarke has tackled the company's legacy vigorously. Before he came aboard Eldercare was basically a specialist property owner, having inherited a portfolio of retirement villages from its biggest shareholder, Eric Watson.
In 2001 earnings at the ebitda (earnings before interest, tax, depreciation, and amortisation) level were negative $1.6 million and restructuring costs took the bottom line to an $8.2 million loss.
Clarke has sold off properties the last went in May and built up four divisions; aged care, diagnostics, dental and rehabilitation. Last year the earnings improvement was already showing through with ebitda of $3.7 million but more restructuring costs pushed the company to a $2.4 million bottom-line loss. This year's results will be announced on July 31. Despite a softer May second half Eldercare says it will do better than its previously forecast $8.8 million of ebitda and $1.4 million of net profit.
ABN-Amro Craigs has an "add" recommendation on the shares and is picking net profits of $1.8 million this year, $3.6 million in 2004 and $4.5 million in 2005. With debt of $32 million at balance date the company is no longer highly geared and its careful acquisition strategy is being financed out of cash flows.
No comments yet
Rio Tinto decision following strategic review of Tiwai
Contact says smelter closure is ‘disappointing’
South Port (SPN) Statement on NZAS Tiwai Point Aluminium Smelter Closure
Rio Tinto announcement on Tiwai Aluminium Smelter
Me Today announces equity raising to accelerate growth
Scott Technology Trading Update; Rising to the COVID Challenge
New non-binding indicative offer received from apvg, shareholder meeting deferred
U.S. Added 4.8 Million Jobs in June as Reopened Businesses Rehired
Auditors have a duty to be alert to fraud
Strong sales recovery but uncertainty remains over economic outlook and potential second wave of COVID-19